ReviewThe lancet. HIV2025

Lenacapavir-associated drug resistance: implications for scaling up long-acting HIV pre-exposure prophylaxis.

Gert van Zyl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.